Mary

Bach

MD, Pharm D

Education & Training: 

Pharm.D. and Certificate in Geriatric Pharmacy, University of Washington School of Pharmacy, Seattle WA (2002)

M.D., University of Washington School of Medicine, Seattle WA (2007)

Internal Medicine Residency, Providence St. Vincent Medical Center, Portland, OR (2007-2010)

Fellowship in Rheumatology, University of Washington Medical Center, Seattle WA (2010-2012)

Publications: 

Selected-

Lin P, Bach M, Asquith M, Lee AY, Akileswaran L, Stauffer P, Davin S, Pan Y, Cambronne ED, Dorris M, Debelius JW, Lauber CL, Ackermann G,Baeza YV, Gill T, Knight R, Colbert RA, Taurog JD, Van Gelder RN, Rosenbaum JT. HLA-B27 and Human β2-Microglobulin Affect the Gut Microbiota of Transgenic Rats. PLoS One. 2014 Aug 20;9(8):e105684. doi: 10.1371/journal.pone.0105684. eCollection 2014. *co-first author

Bach MH, Simkin PA. Uricosuric drugs: the once and future therapy for hyperuricemia?. Curr Opin Rheumatol. 2014 Mar;26(2):169-75.

Bach MH, Sadoun E, Reed MJ. Defects in activation of nitric oxide synthases occur during delayed angiogenesis in aging. Mech Ageing Dev, 2005 Apr;126(4):467-73.

Hazlet TK and Bach MH. The internet, confidentiality, and the pharmacy.coms. Camb Q Healthc Ethics. 2001 Spring;10(2):157-60.